Copyright
©The Author(s) 2023.
World J Clin Cases. Apr 16, 2023; 11(11): 2435-2442
Published online Apr 16, 2023. doi: 10.12998/wjcc.v11.i11.2435
Published online Apr 16, 2023. doi: 10.12998/wjcc.v11.i11.2435
Table 1 Overall patients’ characteristics
| Characteristics | Mean (min-max) | n(%) | |
| Age | 22.8 (15-38) | 30 (100) | |
| Sex | Male | 19 (63) | |
| Female | 11 (37) | ||
| Total | 30 (100) | ||
| Total prescription days | 339.1 (230-1216) | ||
| Total prescription dose (mg) | 4029.7 (230-10495) | ||
| Daily prescription dose (mg/d) | 13.2 (8.01-20) | ||
| Underlying disease | None | 23 (77) | |
| Androgenetic alopecia | 1 (3) | ||
| Asthma | 1 (3) | ||
| Crohn’s disease | 1 (3) | ||
| Ulcerative colitis | 1 (3) | ||
| Seborrheic dermatitis | 1 (3) | ||
| Urticaria | 2 (6) | ||
- Citation: Park YJ, Shin HY, Choi WK, Lee AY, Lee SH, Hong JS. Optimal laboratory testing protocol for patients with acne taking oral isotretinoin. World J Clin Cases 2023; 11(11): 2435-2442
- URL: https://www.wjgnet.com/2307-8960/full/v11/i11/2435.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v11.i11.2435